Understanding Facial Volumisation Anatomy

Why anatomy matters in facial volumisation

Safe and effective facial volumisation requires deep understanding of facial anatomy. The face is a complex three-dimensional structure with multiple tissue layers, each ageing at different rates. Fat compartments deflate and descend, bone resorbs, muscles weaken, and skin loses elasticity, all adding to the aged appearance. Restoring youthful proportions requires addressing volume loss in anatomically precise locations.

Facial fat compartments

The face contains distinct superficial and deep fat compartments that age independently. Understanding their boundaries and relationships is essential for natural-looking volumisation.

Superficial fat compartments

• Nasolabial fat: Descends with ageing, deepening the nasolabial fold
• Medial cheek fat: Ptosis contributes to malar mounding and undereye hollowing
• Lateral orbital fat: Loss creates temporal hollowing
• Jowl fat: Descends below the mandibular border, creating jowling

Deep fat compartments

• Deep medial cheek fat (DMCF): Volume loss here is a primary driver of midface ageing. Restoring DMCF volume lifts the entire midface
• Sub-orbicularis oculi fat (SOOF): Deep to the muscle, its deflation creates undereye hollows and contributes to tear trough deformity
• Buccal fat pad: Contributes to lower face fullness; loss creates a gaunt appearance in some patients

Bony resorption patterns

Facial bones resorb predictably with ageing, creating the skeletal foundation for visible changes. Key resorption sites include the maxilla (reducing midface projection), the mandible (reducing jawline definition), the pyriform aperture (widening the nasal base), and the orbit (enlarging eye sockets and contributing to undereye hollowing).

The layered approach to volumisation

Expert injectors use a deep-to-superficial approach. Deep plane injection restores skeletal support and lifts overlying soft tissue. Superficial injection refines contour and addresses specific surface concerns.

Deep injection (Supraperiosteal/Sub-SMAS)

Firm, cohesive fillers placed on bone or deep to muscle provide structural support. Key areas include the zygomatic arch for midface lift, the mandibular angle for jawline definition, the chin for lower face projection, and the temples for upper face volumisation.

Superficial injection (Subcutaneous/Intradermal)

Softer, more pliable fillers address fine lines, lip enhancement, tear trough correction, and surface irregularities.

Danger Zones

Facial volumisation carries risks related to vascular compromise. Critical danger zones include the glabella (supratrochlear and supraorbital arteries), the nasal dorsum (dorsal nasal artery), the nasolabial fold (angular artery), and the temple (superficial temporal artery and its branches). Practitioners must have thorough anatomical knowledge, appropriate cannula technique for high-risk areas, and immediate access to hyaluronidase for vascular occlusion management.

Age-related treatment planning

Different age groups require different volumisation strategies. Patients aged 25-35 typically need subtle enhancement (lips, cheeks, chin). Ages 35-50 require more significant volume restoration (midface, temples, jawline). Over 50, comprehensive volumisation addressing bone resorption, fat compartment deflation, and skin quality becomes necessary.

Frequently asked questions

Why do some people look overdone after filler?

Overfilling, incorrect placement depth, or failure to account for facial proportions can create an unnatural appearance. Expert injectors focus on restoring natural proportions rather than simply adding volume.

How much filler will I need?

Volume requirements vary significantly by age, anatomy, and goals. A consultation with assessment of all facial thirds guides a personalised treatment plan. Many patients benefit from staged treatment over multiple sessions rather than a single high-volume session.

Is the treatment safe?

In the hands of an experienced, anatomically trained practitioner, facial volumisation is very safe. The most serious risk (vascular occlusion) is rare and manageable with appropriate protocols.